Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
453.4 INR | +3.01% | +4.52% | +5.39% |
May. 15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
Apr. 25 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.39% | 2.88B | |
+34.35% | 705B | |
+30.74% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.74% | 238B | |
-3.48% | 210B | |
+10.37% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- LAURUSLABS Stock
- News Laurus Labs Limited
- Laurus Labs' Consolidated Profit Tanks in Fiscal Q1; Shares Climb 4%